4.7 Article

Is PTEN loss associated with clinical outcome measures in human prostate cancer?

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation

Ji-Hyun Chung et al.

HUMAN MOLECULAR GENETICS (2006)

Article Biochemistry & Molecular Biology

Class reunion: PTEN joins the nuclear crew

ZL Lian et al.

ONCOGENE (2005)

Review Biochemistry & Molecular Biology

Akt-regulated pathways in prostate cancer

PK Majumder et al.

ONCOGENE (2005)

Review Oncology

Current status of the molecular genetics of human prostatic adenocarcinomas

D Karan et al.

INTERNATIONAL JOURNAL OF CANCER (2003)

Review Genetics & Heredity

PTEN: One gene, many syndromes

C Eng

HUMAN MUTATION (2003)

Article Public, Environmental & Occupational Health

Oncogenes and tumor suppressor genes in prostate cancer

W Isaacs et al.

EPIDEMIOLOGIC REVIEWS (2001)

Article Biochemistry & Molecular Biology

IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation

K Reiss et al.

ONCOGENE (2000)

Review Urology & Nephrology

Recent advances in the histopathology and molecular biology of prostate cancer

JL Burton et al.

BJU INTERNATIONAL (2000)